Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-06-23

Clinical Trial Update: Stem Cells and Resynchronization Cardiac [Phase 1]

View source ↗

Summary

Phase 1 clinical study evaluating stem cell therapy with cardiac resynchronization in heart failure; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Instituto de Molestias Cardiovasculares | Conditions: Heart Failure | Phase 1 | Status: UNKNOWN